Skip to content
Z Zendikt
Editorial verdict · Who it’s wrong for

Who shouldn’t buy Ivanti Neurons for MDM?

A direct read on the buyers Ivanti Neurons for MDM is the wrong fit for — sourced from the same editorial team that ranked the full MDM Software (Mobile Device Management) category.

Worst for

Net-new commercial UEM buyers (Intune, Jamf, or Workspace ONE carry less vendor risk), modern tech companies prioritizing admin UX (Kandji wins), or organizations concerned about the 2023-2024 Ivanti security incident history.

For context: who it IS for

Existing MobileIron and Ivanti customers maintaining renewals, federal civilian agencies and DoD contractors requiring FedRAMP Moderate UEM, CMMC-bound defense industrial base manufacturers, and organizations using broader Ivanti Neurons platform.

Target size: 1,000–500,000+ · Federal, DoD, CMMC, and enterprise mixed-fleet

Why we say this

Editorial pulled these weaknesses from Ivanti Neurons for MDM’s product card in our Top 10 Mobile Device Management (MDM) Software for 2026:

  • ! Material security incidents in 2023-2024 (Connect Secure zero-days, EPMM vulnerabilities) damaged trust
  • ! Roadmap clarity post-MobileIron acquisition criticized
  • ! Net-new commercial buyer momentum largely paused
  • ! Admin UX dated relative to Kandji or modern Intune
  • ! Apple depth trails Jamf and Kandji
  • ! PE ownership creates ongoing M&A and packaging uncertainty

If Ivanti Neurons for MDM is wrong for you, consider these instead

Same MDM Software (Mobile Device Management) category, different best-fit buyer.

Related editorial

Last updated 2026-06-07. Editorial verdict based on the published Top 10 Mobile Device Management (MDM) Software for 2026 ranking. Disagree? Tell us.